Congress trades in Editas Medicine (EDIT)
Healthcare · Biotechnology
2 members of Congress have disclosed 4 trades in Editas Medicine (EDIT) since 2017: 1 buy and 3 sales. The most recent was disclosed on May 19, 2023.
- Trades disclosed
- 4
- Members trading
- 2
- Buys / sells
- 1 / 3
- Reported value
- $46K–$165K
Who traded EDIT
- Sen. James M. Inhofe (R-OK)1 buy · 2 sales12Dec 20, 2019
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01May 19, 2023
All trades
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Dec 20, 2019$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (full) Editas Medicine EDIT
$15K–$50K · Traded Feb 4, 2019 · disclosed Dec 20, 2019 · filed 319 days later
- Feb 25, 2019$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (full) Editas Medicine EDIT
$15K–$50K · Traded Feb 4, 2019 · disclosed Feb 25, 2019
- Nov 8, 2017$15K–$50K
Sen. James M. Inhofe (R-OK)
$15K–$50K · Traded Oct 19, 2017 · disclosed Nov 8, 2017
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.